The ROE (Return on Equity) of InVivo Therapeutics Holdings Corp (NVIV) is -66.60%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2022-12-31 | -66.60% |
| 2021-12-31 | -54.64% |
| 2020-12-31 | -47.26% |
| 2019-12-31 | -212.01% |
| 2018-12-31 | -145.38% |
| 2017-12-31 | -264.59% |
| 2016-12-31 | -80.97% |
| 2015-12-31 | -196.75% |
| 2014-12-31 | -309.97% |
| 2013-12-31 | -300.70% |